From vaccine to antibody treatment, here is a roundup of COVID-19 treatment updates

Jun 10, 2020

British Pharma giant, AstraZeneca, who is currently one of the frontrunners in the race for vaccine development has also placed a promising contender in the race to beat COVID-19. Preliminary studies have shown that a blood cancer drug, Calquence, which is manufactured by the firm seems to show positive results in treating COVID-19 positive patients. The results of the same have been published in Science Immunology, which is a medical journal.

The study observed that the drug, which is typically used in cancer treatment was able to suppress and neutralize cytokine storm-causing protein in the virus-infected cells, which has been known to cause mortality in severely affected patients.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *